Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;74(4):665-670.
doi: 10.1002/art.41992. Epub 2022 Mar 3.

VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis

Affiliations

VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis

Francesco Muratore et al. Arthritis Rheumatol. 2022 Apr.

Abstract

Objective: To identify patients with VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome) from a single-center cohort of Italian patients with vasculitis, using a clinically oriented phenotype-first approach.

Methods: We retrospectively reviewed the clinical records of 147 consecutive male patients followed up in our vasculitis clinic from 2013 to date. All patients with a diagnosis of vasculitis and treatment-resistant manifestations of inflammation, persistently elevated inflammation markers, and hematologic abnormalities were identified. Bone marrow aspirates were examined for the presence of vacuoles. Sequencing of ubiquitin-activating enzyme E1 (UBA-1) was performed using genomic DNA from peripheral blood leukocytes or bone marrow tissue.

Results: Seven patients with vasculitis and concomitant features of VEXAS syndrome were identified. A final diagnosis of VEXAS syndrome was made in 3 of the 5 patients who underwent sequencing of UBA-1 (diagnosis was made postmortem for 1 patient). In all 3 patients, examination of the bone marrow aspirate revealed vacuoles characteristic of VEXAS syndrome, and all 3 patients met the definitive World Health Organization criteria for myelodysplastic syndrome. Cytogenetic analysis showed normal karyotypes in all 3 patients.

Conclusion: To our knowledge, this is the first report of VEXAS syndrome associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Our data emphasize the need to consider VEXAS syndrome when evaluating patients with various forms of systemic vasculitis. The novel association between VEXAS syndrome and ANCA-associated vasculitis reported herein warrants further investigation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A, Bone marrow aspirate from patient 7, showing evidence of dysplasia and cytoplasmic vacuolization of the erythroid and myeloid precursor cells. B, Higher‐magnification view of the bone marrow aspirate from patient 7, showing dysplasia (neutrophils with pseudo Pelger‐Huët anomaly) and cytoplasmic vacuolization of the erythroid precursor cells (blue arrows) and myeloid precursor cells (red arrow). Stained with May‐Grünwald‐Giemsa stain; original magnification × 400 in A; × 1,000 in B.

Comment in

References

    1. Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, et al. Somatic mutations in UBA1 and severe adult‐onset autoinflammatory disease. N Engl J Med 2020;383:2628–38. - PMC - PubMed
    1. Ferrada MA, Sikora KA, Luo Y, Wells KV, Patel B, Groarke EM, et al. Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS. Arthritis Rheumatol 2021;73:1886–95. - PubMed
    1. Tsuchida N, Kunishita Y, Uchiyama Y, Kirino Y, Enaka M, Yamaguchi Y, et al. Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis. Ann Rheum Dis 2021 doi: 10.1136/annrheumdis-2021-220089. E‐pub ahead of print. - DOI - PubMed
    1. Md V, Misra S, Li H, Aluru S. Efficient architecture‐aware acceleration of BWA‐MEM for multicore systems. Proc‐2019 IEEE 33rd Int Parallel Distrib Process Symp IPDPS 2019 2019:314–24.
    1. Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 2013;31:213–9. - PMC - PubMed

Publication types

Substances